Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

UCHL5 deubiquitinates TGFB. 3 / 3

| 3

➶

reach

"In addition, we show that UCH37 can deubiquitinate and stabilize the type I TGF-beta receptor."

16027725

➶

reach

"The study hypothesized that Smad7 could act as an adaptor to recruit UCH37 to the type I TGF-beta receptor and showed that UCH37 dramatically up-regulates TGF-beta-dependent gene expression by deubiquitinating and stabilizing the type I TGF-beta receptor [XREF_BIBR]."

18687060

➶

reach

"Wicks et al. reported that UCH37 can deubiquitinate and stabilize type I TGFbeta receptor and augment TGFbeta signaling [XREF_BIBR] (XREF_FIG)."

27844253

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

UCHL5 deubiquitinates TGFB. 3 / 3

Our Sources:

Databases

Reading